CIK 0001001316 · Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363898269
- Phone
- (212) 554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $274,800
- in 1 filing
Net −$274,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-13 | Lonial Sagar Director | Sale | −5,000 | $15.94 | $80K | 108,878 |
| 2024-03-12 | Charney Laurence N Director | Sale | −22,000 | $15.97 | $351K | 215,229 |
| 2024-01-06 | WEISS MICHAEL S CEO | Grant or award | +1,001,908 | 13,074,929 | ||
| 2024-01-05 | Charney Laurence N Director | Sale | −17,500 | $19.03 | $333K | 237,229 |
| 2024-01-05 | Power Sean A CFO | Grant or award | +75,000 | 681,969 | ||
| 2024-01-03 | Power Sean A CFO | Sale | −47,867 | $16.91 | $809K | 606,969 |
| 2023-09-28 | Lonial Sagar Director | Grant or award | −20,000 | 113,878 | ||
| 2023-09-28 | HUME DANIEL Director | Grant or award | +20,000 | 218,239 | ||
| 2023-09-28 | Hoberman Kenneth Director | Grant or award | +20,000 | 242,685 | ||
| 2023-09-28 | Echelard Yann Director | Grant or award | +20,000 | 221,848 | ||
| 2023-09-28 | Charney Laurence N Director | Grant or award | +20,000 | 254,729 | ||
| 2023-08-11 | WEISS MICHAEL S CEO and President | Purchase | +100,000 | $10.13 | $1.0M | 12,073,021 |
| 2023-06-23 | Lonial Sagar Director | Sale | −34,854 | $23.37 | $815K | 93,878 |
| 2023-06-02 | Power Sean A Chief Financial Officer | Sale | −73,647 | $26.70 | $2.0M | 654,836 |
| 2023-03-12 | Power Sean A Chief Financial Officer | Grant or award | +85,000 | 728,483 | ||
| 2023-03-12 | WEISS MICHAEL S CEO and President | Grant or award | +985,000 | 11,973,021 | ||
| 2023-01-06 | Echelard Yann Director | Purchase | +9,000 | $10.64 | $96K | 201,848 |
| 2023-01-04 | Charney Laurence N Director | Sale | −30,000 | $11.10 | $333K | 234,729 |
| 2022-07-20 | WEISS MICHAEL S CEO and President | Grant or award · Stock Option (right to buy) | +1,900,000 | 1,900,000 | ||
| 2022-07-20 | Power Sean A Chief Financial Officer | Grant or award | +75,000 | 643,483 |
Page 3 of 7 · 124 trades